Kantonsspital St.Gallen


Stefan Bilz, Vera Jenni & Andrea Räss

abstract A Multi-Country, Multicenter, Single-Arm, Open-Label Study to Document the Safety, Tolerability and Effect of Alirocumab on atherogenic lipoproteins in High Cardio-Vascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-Modifying Therapies
type of project clinical studies
status completed
start of project 2016
end of project 2018
study design multizentrische, einarmige, offene Studie in mehreren Ländern
responsible person Dr. med. Stefan Bilz